高值医用耗材招标采购对使用心脏起搏器患者的医药费用的影响分析  

Analysis of Medical Expense Burden for Patients with Pacemaker Artificial

作　　者：时先锋[1] 冯占春[1] 王保真[2] 

机构地区：[1]华中科技大学同济医学院医药卫生管理学院,武汉430030 [2]武汉大学社会保障研究中心,武汉430072

出　　处：《中国卫生经济》2007年第5期88-90,共3页Chinese Health Economics

基　　金：国家卫生部与WHO卫生技术合作项目(2004-2005年度)--"医疗卫生管理体制与医疗资源调整研究"内容之一。

摘　　要：目的:了解心脏起搏器类高值医用耗材经过集中招标采购后,其购进价格下调的政策效果及相关费用情况,为卫生部门相应政策的调整提供数据和分析依据。方法:对器材科负责人进行访谈,从相关科室收集数据并进行描述性统计分析。结果:心脏起搏器是影响心血管病患者医疗费用的最主要因素,在各类心脏起搏器加成率均为15%的前提下,不同心血管病患者的支付价均有不同程度的下降。结论:通过高值医用耗材的集中招标采购,能够在一定程度上缩减其流通中的虚高价格,从而减轻心血管病患者的直接医药费用负担。Objective To know the policy effects and related expense after the cost price falling down of high cost medical disposable such as pacemaker artificial purchase by public bidding, supply the health department with data and analysis basis for relevant policy adjustment. Methods Visit the leader of equipment department. Collect the data and make descriptive analysis from related department. Results The pacemaker artificial is the main factor influence the medical expense of patients with cardiovascular disease. In the case of the addition rates of different kinds of pacemaker artificial are 15%, the payment of different patients with cardiovascular disease has dropped in different extent. Conclusion Through public bidding, it can curtail the unreasonable price of high cost medical disposable in circulation to some extent and ease the direct medical expense burden of patients with cardiovascular disease.

关 键 词：心脏起搏器 医用耗材 集中招标采购 费用 

分 类 号：R197.3[医药卫生—卫生事业管理] R541.7[医药卫生—公共卫生与预防医学]